PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
16118254-4	2006	Compared with control (DMSO), 200 microM RSG increased (P < 0.05) AMPKalpha1 activity and phosphorylation of AMPK (Thr172).	Rosiglitazone	41-44	protein kinase AMP-activated catalytic subunit alpha 1	Rattus norvegicus	69-79	
16118254-4	2006	Compared with control (DMSO), 200 microM RSG increased (P < 0.05) AMPKalpha1 activity and phosphorylation of AMPK (Thr172).	Rosiglitazone	41-44	protein kinase AMP-activated catalytic subunit alpha 1	Rattus norvegicus	69-73	
16118254-6	2006	To investigate the effects of chronic RSG treatment on AMPK regulation in skeletal muscle in vivo, obese Zucker rats were randomly allocated into two experimental groups: control and RSG.	Rosiglitazone	38-41	protein kinase AMP-activated catalytic subunit alpha 1	Rattus norvegicus	55-59	
16118254-2	2006	We tested the hypothesis that part of the insulin-sensitizing effect of RSG is mediated through the action of AMP-activated protein kinase (AMPK).	Rosiglitazone	72-75	protein kinase AMP-activated catalytic subunit alpha 1	Rattus norvegicus	140-144	
16118254-3	2006	First, we determined the effect of acute (30-60 min) incubation of L6 myotubes with RSG on AMPK regulation and palmitate oxidation.	Rosiglitazone	84-87	protein kinase AMP-activated catalytic subunit alpha 1	Rattus norvegicus	91-95